CSI Market
Sign In | Register

Neogenomics Inc (NEO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NEO Annual Balance Sheets →
The data below summarizes Neogenomics Inc's balance sheet position from Sep 30 2025 to Sep 30 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent139.28
Cash & Short-term Investments139.00
Accounts receivable213.41
Inventories25.50
Other Current Assets9.12
Prepaid Expense, Current AS22.77
Total Current Assets410.08
Equipment/Property/Plant Net85.94
Goodwill net524.00
Intangible Assets263.63
Other Assets, Noncurrent93.27
Assets Held For Sale Not Part Of Disposal Group Current-
Debt Securities Available For Sale Excluding Accrued Interest Current-
Operating Lease Right Of Use Asset76.70
Total Assets1,376.92
Liabilities
Accounts Payable, Current AC32.93
Employee-related Liabilities, Current AC60.48
Other Liabilities, Current22.77
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.00
Total Current Liabilities116.17
Long-term debt374.69
Convertible Debt, Noncurrent LO374.69
Total Long-term Debt749.38
Financial Instruments, Insurance, Noncurrent1.80
Other liabilities, Noncurrent0.00
Contract With Customer Liability Current0.56
Operating Lease Liability Current4.83
Deferred Income Tax Liabilities Net17.45
Operating Lease Liability Noncurrent61.46
Total Liabilities576.28
Stockholders' Equity
Common Stock Value0.13
Additional Paid In Capital Common Stock1,281.72
Retained Earnings / Accumulated Deficit-456.22
Accumulated Other Comprehensive Income0.00
Other Equity0.00
Common Stockholder's Equity800.64
Total Stockholder's Equity800.64
Liabilities & Stockholder's Equity1,376.92
4 historic quarters locked

Sign in to unlock the full Neogenomics Inc balance sheet history.

Sign In Create Free Account

About Neogenomics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: October 28, 2026
  • Source: neo-20260930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001077183-26-000079

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI